Stocks and Investing Stocks and Investing
Thu, September 14, 2023
Wed, September 13, 2023

Laura Chico Reiterated (VRDN) at Buy and Held Target at $46 on, Sep 13th, 2023


Published on 2024-10-28 06:23:58 - WOPRAI, Laura Chico
  Print publication without navigation


Laura Chico of Wedbush, Reiterated "Viridian Therapeutics, Inc." (VRDN) at Buy and Held Target at $46 on, Sep 13th, 2023.

Laura has made no other calls on VRDN in the last 4 months.



There are 7 other peers that have a rating on VRDN. Out of the 7 peers that are also analyzing VRDN, 0 agree with Laura's Rating of Hold.



These are the ratings of the 7 analyists that currently disagree with Laura


  • Douglas Tsao of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $37 on, Thursday, August 10th, 2023
  • Serge Belanger of "Needham" Maintained at Strong Buy with Decreased Target to $40 on, Thursday, August 10th, 2023
  • Leland Gershell of "Oppenheimer" Maintained at Buy with Decreased Target to $35 on, Wednesday, August 9th, 2023
  • Gregory Renza of "RBC Capital" Reiterated at Buy and Held Target at $44 on, Wednesday, August 9th, 2023
  • Jason Butler of "JMP Securities" Maintained at Buy with Decreased Target to $42 on, Wednesday, August 9th, 2023
  • Julian Harrison of "BTIG" Initiated at Strong Buy and Held Target at $46 on, Wednesday, June 14th, 2023
  • Tiago Fauth of "Credit Suisse" Initiated at Buy and Held Target at $51 on, Wednesday, June 14th, 2023

Contributing Sources